CGTN: What Are Generations of Chinese Communists Striving For?
27.2.2021 18:36:00 EET | Business Wire | Press release
The Communist Party of China (CPC), the ruling party of the world's most populous nation and the second largest economy, is turning 100 this year. What has been motivating the CPC to fight against one challenge after another over the past century?
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210227005021/en/
"The original aspiration and the mission of Chinese Communists is to seek happiness for the Chinese people and rejuvenation for the Chinese nation," General Secretary Xi Jinping of the CPC Central Committee said in his report to the 19th CPC National Congress in October 2017.
"This founding aspiration, this mission, is what inspires the Chinese Communists to advance," Xi said.
Self-discipline, selflessness
In March 2018, Xi, also the Chinese president, further explained the cause pursued by the CPC with a quote from an ancient poem: "A virtuous person is as sharp-sighted as a clear mirror hanging high, a selfless person is just like a lit candle giving all of its light to others."
He made the quotation at a symposium to commemorate the 120th birthday of late Premier Zhou Enlai (1898-1976), who joined the CPC in 1921, the year when the Party was founded.
"The lofty character of comrade Zhou Enlai, who selflessly pursued a just cause for the common good throughout his life, vividly reflects the traditional virtue of the Chinese nation and good moral qualities of the Chinese Communists, and will forever earn the respect of future generations," said Xi.
The comments "not only aimed to remember the noble character of Zhou who was self-disciplined, upright, honest and selfless, but also to encourage today's Communists to stay true to their original aspirations of the Party and shoulder their responsibilities," said Meng Man, a history professor at Minzu University of China.
New challenges, same aspiration
The number of the CPC members has exceeded 90 million, and China has become a much stronger nation than 100 years ago and the early decades of the People's Republic of China, but the aspiration of the Chinese Communists remains unchanged.
"To meet the people's desire for a happy life is our mission," Xi said when meeting the press after being elected as general secretary of the CPC Central Committee in November 2012.
Three years later, the communique of the fifth plenary session of the 18th CPC Central Committee underscored a people-centered development philosophy, stressing that China's development must be for the people and by the people, and its fruits shared among the people.
The notion was highlighted again in the CPC Central Committee's proposals for formulating the 14th Five-Year Plan (2021-2025) for National Economic and Social Development and the Long-Range Objectives Through the Year 2035, which called for efforts to promote common prosperity for everyone.
China, in recent years, has been striving to build a moderately prosperous society in all respects and pursuing more balanced development. The CPC members have played leading roles in a nationwide poverty alleviation campaign to make sure nobody is left behind.
Over the past eight years, more than three million public sector officials were sent from cities and towns to villages to fight against poverty on the front lines and over 1,800 people died during the fight, Xi said on Thursday after announcing the country's "complete victory" in eradicating absolute poverty.
Putting people's life and health first, China has taken strict measures to battle the COVID-19 pandemic and effectively contained the virus, thanks to people from all walks of life for their efforts and sacrifices, particularly the CPC members.
More than 39 million CPC members fought the virus at the front line, and more than 13 million volunteered their services. Nearly 400 CPC members have defended others' lives and safety at the cost of their own.
When many parts of the country grappled with severe floods last summer, the Organization Department of the CPC Central Committee issued a circular to call on primary-level CPC organizations and members to fully play their role in flood control and relief work, urging them to ensure the safety of people's lives and property.
As China embarks on a new journey to fully build a modern socialist country, today's Chinese Communists – putting the people's and the nation's interests above those of themselves – are gearing up to take on their responsibilities as the older generations did.
Original article: https://news.cgtn.com/news/2021-02-27/What-are-generations-of-Chinese-Communists-striving-for--YdM2IOWzO8/index.html
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210227005021/en/
Contact information
Jiang Simin
jiang.simin@cgtn.com
+86 18826553286
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Estithmar Holding Pays the Third Semi-Annual coupon of the 8.75% Sukuk Tranche12.3.2026 22:50:00 EET | Press release
Estithmar Holding Q.P.S.C. has paid the third semi-annual coupon of its Qatari Riyal-denominated Sukuk (first tranche), at an annual profit rate of 8.75%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312880092/en/ Estithmar Holding Pays the Third Semi-Annual coupon of the 8.75% Sukuk Tranche (Photo: AETOSWire) The first tranche, part of the company’s broader Sukuk program valued at QAR 3.4 billion and listed on the London Stock Exchange’s International Securities Market, was issued in August 2024. The issuance attracted a diverse pool of institutional investors including banks, insurance companies, and asset managers, with strong interest from both government-affiliated and private institutions. This demand reflects growing investor confidence in Estithmar Holding’s ability to deliver sustained value to stakeholders. EstithmarHolding was recently included in the FTSE Russell Global Equity Index, in Qatar’s Mid-Cap segme
REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 202512.3.2026 16:38:00 EET | Press release
Today the Board of Directors of Reply S.p.A. [MTA, STAR: REY] approved the draft financial statement for the year 2025, which will be submitted for approval to the Shareholders’ Meeting to be held in first call in Turin on 23 April 2026. The Reply Group closed 2025 with a consolidated turnover of €2,483.6 million, an increase of 8.0% compared to €2,300.5 million in 2024. All indicators are positive for the period. Consolidated EBITDA was €467.6 million, an increase of 13.9% compared to €410.6 million at December 2024. EBIT, from January to December, was at €391.7 million, which is an increase of 18.5% compared to €330.4 million at December 2024. The Group net profit was at €250.9 million. In 2024, the corresponding value was €211.1 million. Following the results achieved in 2025, the Reply Board of Directors decided to propose to the next Shareholders’ Meeting a dividend distribution of €1.35 per share, which will be payable on 20 May 2026, with dividend date set on 18 May 2026 (record
LZE GmbH Introduces Fraunhofer’s RFicient® Technology to the Market12.3.2026 15:51:00 EET | Press release
LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step for long-lasting, low-maintenance IoT products. LZE GmbH drives technology transfer to market: standard chip availability for close-to-production applications As a bridge between research and industry, LZE GmbH is making it easier for companies to access innovative technologies and helping them to quickly and reliably transform new developments into market-ready solutions. With RFicient®-IC (FH101RF), LZE is providing another high-tech product that comes directly from Fraunhofer research and can now be ordered in volume and integrated into close-to-production product development for t
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing12.3.2026 15:30:00 EET | Press release
Owkin, the AI company on a mission to solve the complexity of biology, today announced the spin out of Waiv, formerly known as Owkin Dx. The move follows significant investor interest and positions Waiv to bring AI-powered precision testing for better identification of patients in the clinic and in clinical trials, to transform patient care. This follows on from the successful launch of Bioptimus, an Owkin incubated company, in February 2024. Waiv translates AI innovation into real-world clinical impact, developing tests that predict biomarkers and patient outcomes, including RlapsRisk BC for prognostic risk profiling. With multiple tests already in use in clinical settings, its deployment platform Destra, and collaborations with leading pharmaceutical companies, including MSD since 2023 for MSIntuit, Waiv is establishing itself as a leader in translational medical AI. Waiv leverages a decade of Owkin's foundational medical AI research, including access to an extensive patient data net
RQM+ Launches SMART Solutions Life Cycle Partnership Model12.3.2026 15:30:00 EET | Press release
RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech companies across the entire product life cycle to help reduce risk from early development through post-market. “MedTech companies are navigating unprecedented complexity as regulatory expectations evolve, product innovation accelerates, and post-market expectations are expanding,” said John Potthoff, Ph.D., chief executive officer of RQM+. “SMART Solutions moves beyond traditional consulting by providing an integrated life cycle partnership that helps sponsors gain earlier clarity, reduce risk, and execute complex programs
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
